文献速递免疫规划

使用C群脑膜炎球菌荚膜多糖结合疫苗加强剂展示婴儿期接种一剂或两剂疫苗儿童的免疫记忆

Use of a booster dose of capsular group C meningococcal glycoconjugate vaccine to demonstrate immunologic memory in children primed with one or two vaccine doses in infancy.
PubMed 文献 · Vaccine · 2016-10-28

本研究为一项随机对照试验的一部分,在269名儿童亚组中,比较婴儿期接受减少剂量MenCC疫苗 priming(一剂MenC-CRM/MenC-TT或两剂MenC-CRM)与未接种组,在12月龄接种Hib-MenC-TT加强剂后6天和28天的MenC rSBA滴度及MenC特异性IgG记忆B细胞变化。结果显示,primed组加强后6天MenC rSBA滴度和记忆B细胞升高显著高于未接种组;单剂MenC-TT priming组rSBA升高最高;加强后28天较6天,单剂MenC-TT/MenC-CRM priming组rSBA显著高于未接种或两剂MenC-CRM组。结论认为MenCC加强接种可展示免疫记忆,但受婴儿期priming疫苗类型和剂数影响。

要点

  • 12月龄MenCC加强后6天,primed组MenC rSBA滴度和IgG记忆B细胞升高显著高于未接种组。
  • 单剂MenC-TT priming组MenC rSBA滴度升高幅度最高。
  • 加强后28天较6天,单剂MenC-TT/MenC-CRM priming组rSBA显著高于未接种或两剂MenC-CRM组。

核心结论

  • MenCC加强接种可展示免疫记忆,但受婴儿期priming所用MenCC疫苗类型和剂数影响。
  • MenC rSBA应答可用于展示成功的免疫priming。

研究设计与样本

  • 本研究为一项随机对照试验的一部分,研究Hib-MenC-TT加强剂在婴儿期接受减少剂量MenCC疫苗priming方案(一剂MenC-CRM/MenC-TT或两剂MenC-CRM)与未priming组中的免疫原性。
  • 在269名儿童亚组中,于12月龄加强接种前及后6天和28天检测MenC rSBA滴度(兔补体)和MenC特异性IgG记忆B细胞变化。

主要发现

  • 12月龄MenCC加强后6天,primed组MenC rSBA滴度和MenC特异性IgG记忆B细胞的升高显著高于婴儿期MenCC未接种组。
  • 与其他所有组相比,接受一剂MenC-TT priming的参与者MenC rSBA滴度升高最高。
  • 加强后28天较6天,婴儿期接受单剂MenC-TT/MenC-CRM疫苗priming者MenC rSBA滴度显著高于未priming者或接受两剂MenC-CRM疫苗priming者。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Use of a polysaccharide vaccine challenge to demonstrate immunologic memory after priming with capsular group C meningococcal conjugate vaccines (MenCC) risks induction of immunologic hyporesponsiveness. For this reason, MenCC vaccines are now used as probes of immunologic memory, however, no studies have demonstrated their ability to distinguish primed from unprimed children. METHODS: This study was part of a randomised controlled trial investigating the immunogenicity of a booster dose of the combined Haemophilus influenzae type b and MenC-tetanus toxoid vaccine (Hib-MenC-TT) in infants receiving reduced dose MenCC vaccine priming schedules (one MenC-CRM/MenC-TT or two MenC-CRM vaccine doses) compared with an unprimed group. Antibody kinetics were studied in a subset of 269 children by measuring changes in the MenC serum bactericidal antibody, using rabbit complement, (MenC rSBA) titres and MenC specific IgG memory B-cells before and at 6 and 28days following the 12month booster vaccination. RESULTS: At 6days after the 12monthMenCC vaccine, the rise in MenC rSBA titres and MenC specific IgG memory B-cells of the primed groups were significantly higher than the infant MenCC naïve group. Participants primed with one MenC-TT dose had the highest increase in MenC rSBA titres compared with all other groups. The MenC rSBA titres at the 28th compared with the 6th day after boosting was significantly higher in those primed with a single MenC-TT/MenC-CRM vaccine in infancy compared with those who were not primed or who were primed with two doses of the MenC-CRM vaccine. CONCLUSION: Immunologic memory can be demonstrated by a MenCC booster vaccination but is affected by the type and number of MenCC doses used for infant priming. The MenC rSBA responses can be used to demonstrate successful immunologic priming.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Pace D, Khatami A, Attard-Montalto S, et al. Use of a booster dose of capsular group C meningococcal glycoconjugate vaccine to demonstrate immunologic memory in children primed with one or two vaccine doses in infancy. Vaccine. 2016. PMID: 28029540. doi:10.1016/j.vaccine.2016.10.038

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。